Glenbrook Capital Management Buys 42,739 Shares of Senestech (NASDAQ:SNES) Stock

Senestech, Inc. (NASDAQ:SNES) major shareholder Glenbrook Capital Management purchased 42,739 shares of the stock in a transaction dated Monday, February 2nd. The stock was acquired at an average cost of $1.98 per share, with a total value of $84,623.22. Following the transaction, the insider directly owned 593,785 shares in the company, valued at approximately $1,175,694.30. This trade represents a 7.76% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Major shareholders that own more than 10% of a company’s stock are required to disclose their sales and purchases with the SEC.

Glenbrook Capital Management also recently made the following trade(s):

• On Friday, January 30th, Glenbrook Capital Management bought 5,399 shares of Senestech stock. The stock was bought at an average price of $1.87 per share, for a total transaction of $10,096.13.

Senestech Stock Down 7.4%

SNES traded down $0.15 during trading on Tuesday, hitting $1.88. The stock had a trading volume of 70,832 shares, compared to its average volume of 42,879. Senestech, Inc. has a twelve month low of $1.30 and a twelve month high of $6.24. The stock has a 50 day simple moving average of $2.35 and a two-hundred day simple moving average of $3.61. The company has a debt-to-equity ratio of 0.01, a quick ratio of 14.73 and a current ratio of 15.75. The company has a market capitalization of $9.81 million, a PE ratio of -0.52 and a beta of 0.22.

Senestech (NASDAQ:SNES) last posted its quarterly earnings data on Monday, November 10th. The company reported ($0.28) EPS for the quarter, topping the consensus estimate of ($0.35) by $0.07. The business had revenue of $0.69 million during the quarter, compared to the consensus estimate of $0.73 million. Senestech had a negative net margin of 253.54% and a negative return on equity of 98.35%. On average, research analysts predict that Senestech, Inc. will post -10.22 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Senestech in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold”.

Institutional Trading of Senestech

A number of large investors have recently modified their holdings of SNES. Geode Capital Management LLC purchased a new stake in shares of Senestech during the second quarter worth approximately $59,000. Diversify Advisory Services LLC purchased a new stake in Senestech during the 4th quarter worth about $34,000. Essex Investment Management Co. LLC acquired a new position in shares of Senestech during the 3rd quarter worth about $115,000. Millennium Management LLC purchased a new position in shares of Senestech in the 3rd quarter valued at about $126,000. Finally, Jane Street Group LLC acquired a new stake in shares of Senestech during the 2nd quarter worth about $161,000. Hedge funds and other institutional investors own 5.19% of the company’s stock.

About Senestech

SenesTech, Inc (NASDAQ: SNES) is a biotechnology company specializing in non-lethal pest management solutions. The company’s core focus is the development and commercialization of fertility-based control methods for commensal rodents, providing an alternative to traditional rodenticides. By targeting the reproductive cycle of rats, SenesTech aims to reduce rodent populations over time without the use of toxic chemicals, offering a more sustainable approach for pest management professionals.

The company’s flagship product, ContraPest®, is an EPA-registered liquid bait that disrupts rodent reproduction.